438 related articles for article (PubMed ID: 2142871)
1. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
[TBL] [Abstract][Full Text] [Related]
2. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.
Simard J; Hatton AC; Labrie C; Dauvois S; Zhao HF; Haagensen DE; Labrie F
Mol Endocrinol; 1989 Apr; 3(4):694-702. PubMed ID: 2725533
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
Hackenberg R; Schulz KD
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):113-7. PubMed ID: 8603031
[TBL] [Abstract][Full Text] [Related]
5. Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer.
Dumont M; Dauvois S; Simard J; Garcia T; Schachter B; Labrie F
J Steroid Biochem; 1989; 34(1-6):397-402. PubMed ID: 2626033
[TBL] [Abstract][Full Text] [Related]
6. Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells.
Simard J; de Launoit Y; Haagensen DE; Labrie F
Endocrinology; 1992 Mar; 130(3):1115-21. PubMed ID: 1537279
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells.
Blais Y; Sugimoto K; Carrière MC; Haagensen DE; Labrie F; Simard J
Int J Cancer; 1995 Sep; 62(6):732-7. PubMed ID: 7558422
[TBL] [Abstract][Full Text] [Related]
8. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057
[TBL] [Abstract][Full Text] [Related]
9. Potent antagonism between estrogens and androgens on GCDFP-15 expression and cell growth in the ZR-75-1 human breast cancer cells.
Labrie F; Simard J; Poulin R; Hatton AC; Labrie C; Dauvois S; Zhao HF; Petitclerc L; Couët J; Dumont M
Ann N Y Acad Sci; 1990; 586():174-87. PubMed ID: 2356999
[No Abstract] [Full Text] [Related]
10. Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.
Dauvois S; Simard J; Dumont M; Haagensen DE; Labrie F
Mol Cell Endocrinol; 1990 Oct; 73(2-3):171-8. PubMed ID: 2269395
[TBL] [Abstract][Full Text] [Related]
11. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
[TBL] [Abstract][Full Text] [Related]
12. Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells.
Blais Y; Sugimoto K; Carriere MC; Haagensen DE; Labrie F; Simard J
Int J Cancer; 1994 Nov; 59(3):400-7. PubMed ID: 7927949
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells.
Blais Y; Gingras S; Haagensen DE; Labrie F; Simard J
Mol Cell Endocrinol; 1996 Jul; 121(1):11-8. PubMed ID: 8865161
[TBL] [Abstract][Full Text] [Related]
14. Androgens and breast cancer.
Labrie F; Simard J; de Launoit Y; Poulin R; Thériault C; Dumont M; Dauvois S; Martel C; Li SM
Cancer Detect Prev; 1992; 16(1):31-8. PubMed ID: 1551135
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
Poulin R; Labrie F
Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
[TBL] [Abstract][Full Text] [Related]
16. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
Poulin R; Baker D; Labrie F
Breast Cancer Res Treat; 1988 Oct; 12(2):213-25. PubMed ID: 3242650
[TBL] [Abstract][Full Text] [Related]
17. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line.
Poulin R; Simard J; Labrie C; Petitclerc L; Dumont M; Lagace L; Labrie F
Endocrinology; 1989 Jul; 125(1):392-9. PubMed ID: 2661209
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells.
Simard J; Veilleux R; de Launoit Y; Haagensen DE; Labrie F
Cancer Res; 1991 Aug; 51(16):4336-41. PubMed ID: 1868457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
